Michael Garshick News Today

Growing evidence suggests that a guideline-directed, treat-to-target strategy in patients with gout not only controls the disease but also reduces cardiovascular risks.

Colchicine, a legacy drug that received a new indication in 2023 for cardiovascular disease, can treat arterial inflammation after a heart attack, a principal investigator of clinical trials said.

Researchers report that severe cases of psoriasis can affect a person's blood flow and subsequently increase their risk of cardiovascular disease

Nonrandomized trial shows 5%-6% reduction in both visceral and subcutaneous fat, but no effect on aortic vascular inflammation.

There has been a keen interest in understanding how psoriasis therapies impact cardiovascular risk, said Joel Gelfand, MD, who presented the findings at the American Academy of Dermatology meeting.